Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hyperthermia × spartalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 7 Melanoma 7 Triple Negative Breast Neoplasms 6 Pancreatic Neoplasms 6 Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Lymphoma 4 Liver Neoplasms 4 Lung Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Multiple Myeloma 2 Locally Advanced Rectal Cancer 2 Kidney Neoplasms 2 Hematologic Diseases 2 Esophageal Squamous Cell Carcinoma 2 Colonic Neoplasms 2 Cholangiocarcinoma 2 Adenocarcinoma 2 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor, Adult 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1

Interventions

Melphalan 3 Diathermy 2 Cytoreduction Surgical Procedures 2 Conization 2 tislelizumab 1 spartalizumab 1 sodium thiosulfate 1 Radiotherapy 1 Leucovorin 1 Laparotomy 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Floxuridine 1 Drug Therapy 1 Cryotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06022692 2023-09-05

HEAIS001

Zhejiang Hospital

Phase 1/2 Completed

Gastrointestinal

Hyperthermia, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡